News
Better Marijuana Stock: Green Thumb Industries vs. OrganiGram
You could make a pretty compelling argument that Green Thumb Industries (OTC: GTBIF) ranks at the top of the list of U.S.-based cannabis operators. You could also make a similar argument that
Moderna Stock: Buy, Sell, or Hold?
While the COVID-19 pandemic has caused upheaval throughout the world, it has also served as a major catalyst for some stocks. You can definitely include Moderna (NASDAQ: MRNA) in the group. The
Marijuana Stocks Could Soar If Canopy Growth's "Magic Number" for U.S. Cannabis Legalization Is Right
Canopy Growth (NYSE: CGC) CEO David Klein has a "magic number" in mind for when the U.S. will legalize cannabis. In an interview with CNBC's Jim Cramer last week, Klein said that he expects cannabis
Should You Buy Fastly Stock Now?
Cloud computing specialist Fastly (NYSE: FSLY) is on a roll. The stock has quadrupled in value over the last quarter and continues to set new all-time highs nearly every day. Share prices doubled in
Better Buy: Illumina vs. Guardant Health
In recent years, investors have been drawn to healthcare companies focused on genetic research. This field has transformed science and medicine, and its innovations have made some investors wealthy
2 Biotech Stocks With Major Incoming Catalysts
Over the past three months, the Nasdaq Biotechnology index has risen around 41%, thanks largely to the hordes of investors turning their attention to shares of companies with potential coronavirus
1 Top-Notch Vacation Stock to Buy as the Economy Reopens
COVID-19 has done some serious damage to the economy. But some sectors, such as dine-in restaurants, travel, and tourism, have been hit exceptionally hard. Many stocks in these sectors have
Best Investment Strategies for Your 401(k) Plan
Roughly 58% of Americans say the coronavirus pandemic is having a negative effect on their retirement savings, while 72% say the crisis has made them rethink their retirement savings strategy
This Revolutionary Biotech Is Shrouded in Mystery. Is It a Buy?
Since the beginning of the year, shares of an under-the-radar biotech company called Dyadic International (NASDAQ: DYAI) have rallied more than 87%. Without a doubt, the company is a tough nut to
20% of Workers Risk Falling Dangerously Short on Retirement Income for This Reason
The money you get from Social Security won't be enough to cover your retirement expenses entirely. Those benefits will only replace about 40% of your pre-retirement income if you earn an average
Is It Time to Buy Brookfield Renewable Stock?
The COVID-19 pandemic has disrupted entire industries in ways that will change them permanently. Airlines, cruise operators, and many brick-and-mortar retailers are the obvious losers, while many
3 Stocks to Bankroll Your Retirement
When planning for retirement, many investors stock their portfolio with companies that offer a growing and generous dividend yield, but whose growth prospects fall somewhere between slim and none at
3 Top Stocks Millennial Investors Should Be Buying
Whether you're a tenured investor or relatively new to the investment world, this has been a head-scratcher of a year. In roughly a four-month span, the benchmark S&P 500 has crammed in about 10
I'm Not Factoring in Social Security When Figuring Out My Retirement Goals. Here's Why
When you're figuring out your retirement savings goals, one of the key steps is to think about how much income you'll need in retirement and where it will come from.
For most people, retirement
The Best Stocks to Invest in If You Have $3,000
For more than four months, investors have been taken on one heck of a roller-coaster ride. In a span of less than five weeks between February 19 and March 23, the broad-based S&P 500 entered bear
AstraZeneca COVID-19 Vaccine Shows Promise in 2-Dose Animal Trial
The results of a clinical trial in pigs administered AstraZeneca's (NYSE: AZN) COVID-19 vaccine indicate that two doses of it could be effective in treating the disease. On Tuesday, the Pirbright
Aerovironment Inc (AVAV) Q4 2020 Earnings Call Transcript
Aerovironment Inc (NASDAQ: AVAV)Q4 2020 Earnings CallJun 23, 2020, 4:30 p.m. ET
Steven Gitlin -- Chief Marketing Officer, Vice President Investor Relations
La-Z-Boy Reports Q4 and Full Year Results, Beats Expected EPS, Falls Short on Revenue
Manufacturer of upholstered recliners and other furniture La-Z-Boy (NYSE: LZB) reported its fiscal 2020 fourth quarter and full year results today, revealing it has beaten analyst predictions on
W&T; Offshore, Inc. (WTI) Q1 2020 Earnings Call Transcript
W&T Offshore, Inc. (NYSE: WTI)Q1 2020 Earnings CallJun 23, 2020, 10:00 a.m. ET
Operator
Source Fool.com
Report: Luckin Coffee Hires Financial Advisor Experienced in Distressed Situations
Battered by missteps and bad news of late, it seems Luckin Coffee (NASDAQ: LK) is turning to a third party for some help. Reuters is reporting that the Chinese takeout java specialist has hired Los
Why Luckin Coffee Stock Plunged Today
Shares of Luckin Coffee (NASDAQ: LK) fell more than 12% on Tuesday after the Chinese coffeehouse company disclosed that it received another delisting notice from Nasdaq.
Luckin Coffee said that it
Tyson, Smithfield, and Others Now Under Senate Scrutiny for Pork Exports
Additional investigations into meat-packing company practices during the COVID-19 pandemic are now looming for Tyson Foods (NYSE: TSN), along with privately held Smithfield Foods, JBS Foods
Why Beyond Meat Stock Fell Today
Shares of Beyond Meat (NASDAQ: BYND) declined by 4.3% on Tuesday after Starbucks (NASDAQ: SBUX) announced that it would sell food made by a rival meat alternatives company.
Starbucks will now offer
Deal for Largest-Ever New York City Warehouse Provides Insight Into Amazon's Strategy
Amazon.com (NASDAQ: AMZN) inked an agreement to lease for a 1-million-square-foot warehouse in Queens, the largest such facility in New York City, according to a report that first appeared in
Gilead Sciences Bets $275 Million on an Oncology Start-Up
Gilead Sciences (NASDAQ: GILD) expanded its cancer immunotherapy footprint on Tuesday with a large investment into a privately held biotechnology company called Pionyr Immunotherapeutics. Gilead